During the past decade, Azienda ULSS 8 Berica conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda ULSS 8 Berica" #1 sponsor was "Bristol-Myers Squibb" with 1 trials, followed by "Celgene" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Janssen-Cilag S.p.A." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda ULSS 8 Berica" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Azienda ULSS 8 Berica" are "Advanced Cholangiocarcinoma" (1 trials), "Advanced Colorectal Cancer" (1 trials), "Cancer, Hepatocellular" (1 trials), "Depressive Disorder, Major" (1 trials) and "FGFR2 Gene Rearrangements" (1 trials). Many other conditions were trialed in "Azienda ULSS 8 Berica" in a lesser frequency.

Most popular intervention types in "Azienda ULSS 8 Berica" are "Drug" (5 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Archival Tumor Tissue Sample" (1 trials), "Cisplatin/Gemcitabine" (1 trials), "Cyclophosphamide" (1 trials), "DS-8201a 5.4 mg/kg Q3W" (1 trials) and "DS-8201a 6.4 mg/kg Q3W" (1 trials). Other intervention names were less common.

The vast majority of trials in "Azienda ULSS 8 Berica" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Azienda ULSS 8 Berica". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Azienda ULSS 8 Berica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Azienda ULSS 8 Berica, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Azienda ULSS 8 Berica has several departments that took part in Clinical trials: "Ospedale S. Bortolo ULSS 6, U.O. di Oncologia Medica" - 14 trials, "Ospedale Civile - U.O.C. Cardiologia" - 6 trials, "Ospedale Civile San Bortolo - U.O.C. Cardiologia" - 2 trials